L1 cell adhesion molecule as a novel independent poor prognostic factor in gallbladder carcinoma

Human Pathology

Volumn 42, Issue 10, 2011, Pages 1476-1483

  Choi, Song Yi ^a,d   Jo, Young Suk ^a   Huang, Song Mei ^a   Liang, Zhe Long ^a   Min, Jeong Ki ^b   Hong, Hyo Jeong ^c   Kim, Jin Man ^a  

^a Chungnam National University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^c Kangwon National University   (South Korea)

^d Chungbuk National University Hospital   (South Korea)

Author keywords

Gallbladder carcinoma; L1 cell adhesion molecule; Prognosis; Survival analysis

Indexed keywords

BETA CATENIN; CELL ADHESION MOLECULE; L1 CELL ADHESION MOLECULE; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGE; AGED; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DISTANT METASTASIS; FEMALE; GALLBLADDER CARCINOMA; GALLBLADDER EPITHELIUM; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PERINEURIUM; PROGNOSIS; PROTEIN EXPRESSION; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BETA CATENIN; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; NEURAL CELL ADHESION MOLECULE L1; PROGNOSIS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 80053200215     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.01.003     Document Type: Article

References (45)

1. Jemal A., Siegel R., and Ward E. Cancer statistics, 2006 CA Cancer J Clin 56 2006 106 130
2. Gourgiotis S., Kocher H.M., and Solaini L. Gallbladder cancer Am J Surg 196 2008 252 264 (Pubitemid 351970506)
3. Balachandran P., Agarwal S., and Krishnani N. Predictors of long-term survival in patients with gallbladder cancer J Gastrointest Surg 10 2006 848 854 (Pubitemid 43850375)
4. Varga M., Obrist P., and Schneeberger S. Overexpression of epithelial cell adhesion molecule antigen in gallbladder carcinoma is an independent marker for poor survival Clin Cancer Res 10 2004 3131 3136 (Pubitemid 38619694)
5. Park J.S., Yoon D.S., and Kim K.S. Analysis of prognostic factors after curative resection for gallbladder carcinoma Korean J Gastroenterol 48 2006 32 36
6. Malka D., Boige V., and Dromain C. Biliary tract neoplasms: update 2003 Curr Opin Oncol 16 2004 364 371 (Pubitemid 38870043)
7. Takagi S., Naito E., and Yamanouchi H. Mutation of the p53 gene in gallbladder cancer Tohoku J Exp Med 172 1994 283 289
8. Itoi T., Takei K., and Shinohara Y. K-ras codon 12 and p53 mutations in biopsy specimens and bile from biliary tract cancers Pathol Int 49 1999 30 37 (Pubitemid 29421945)
9. Yoshida S., Todoroki T., and Ichikawa Y. Mutations of p16Ink4/CDKN2 and p15Ink4B/MTS2 genes in biliary tract cancers Cancer Res 55 1995 2756 2760
10. Rathjen F.G., and Schachner M. Immunocytological and biochemical characterization of a new neuronal cell surface component (L1 antigen) which is involved in cell adhesion EMBO J 3 1984 1 10
11. Moos M., Tacke R., and Scherer H. Neural adhesion molecule L1 as a member of the immunoglobulin superfamily with binding domains similar to fibronectin Nature 334 1988 701 703
12. Brummendorf T., and Rathjen F.G. Cell adhesion molecules: 1. Immunoglobulin superfamily Protein Profile 2 1995 963 1108
13. Debiec H., Christensen E.I., and Ronco P.M. The cell adhesion molecule L1 is developmentally regulated in the renal epithelium and is involved in kidney branching morphogenesis J Cell Biol 143 1998 2067 2079 (Pubitemid 29022625)
14. Ebeling O., Duczmal A., and Aigner S. L1 adhesion molecule on human lymphocytes and monocytes: expression and involvement in binding to alpha v beta 3 integrin Eur J Immunol 26 1996 2508 2516 (Pubitemid 26340957)
15. Pancook J.D., Reisfeld R.A., and Varki N. Expression and regulation of the neural cell adhesion molecule L1 on human cells of myelomonocytic and lymphoid origin J Immunol 158 1997 4413 4421 (Pubitemid 127483945)
16. Thor G., Probstmeier R., and Schachner M. Characterization of the cell adhesion molecules L1, N-CAM and J1 in the mouse intestine EMBO J 6 1987 2581 2586
17. Raveh S., Gavert N., and Ben-Ze'ev A. L1 cell adhesion molecule (L1CAM) in invasive tumors Cancer Lett 282 2009 137 145
18. Izumoto S., Ohnishi T., and Arita N. Gene expression of neural cell adhesion molecule L1 in malignant gliomas and biological significance of L1 in glioma invasion Cancer Res 56 1996 1440 1444 (Pubitemid 26080991)
19. Hoefnagel C.A., Rutgers M., and Buitenhuis C.K. A comparison of targeting of neuroblastoma with mIBG and anti L1-CAM antibody mAb chCE7: therapeutic efficacy in a neuroblastoma xenograft model and imaging of neuroblastoma patients Eur J Nucl Med 28 2001 359 368
20. Thies A., Schachner M., and Moll I. Overexpression of the cell adhesion molecule L1 is associated with metastasis in cutaneous malignant melanoma Eur J Cancer 38 2002 1708 1716
21. Fogel M., Gutwein P., and Mechtersheimer S. L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas Lancet 362 2003 869 875 (Pubitemid 37130096)
22. Allory Y., Matsuoka Y., and Bazille C. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas Clin Cancer Res 11 2005 1190 1197 (Pubitemid 40175770)
23. Talantov D., Mazumder A., and Yu J.X. Novel genes associated with malignant melanoma but not benign melanocytic lesions Clin Cancer Res 11 2005 7234 7242 (Pubitemid 41507680)
24. Gavert N., Conacci-Sorrell M., and Gast D. L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers J Cell Biol 168 2005 633 642 (Pubitemid 40271028)
25. Kaifi J.T., Zinnkann U., and Yekebas E.F. L1 is a potential marker for poorly-differentiated pancreatic neuroendocrine carcinoma World J Gastroenterol 12 2006 94 98 (Pubitemid 43126090)
26. Boo Y.J., Park J.M., and Kim J. L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer Ann Surg Oncol 14 2007 1703 1711 (Pubitemid 46790990)
27. Kaifi J.T., Reichelt U., and Quaas A. L1 is associated with micrometastatic spread and poor outcome in colorectal cancer Mod Pathol 20 2007 1183 1190 (Pubitemid 47609067)
28. Kim H.S., Yi S.Y., and Jun H.J. L1 cell adhesion molecule as a predictor for recurrence in pulmonary carcinoids and large-cell neuroendocrine tumors APMIS 117 2009 140 146
29. Li S., Jo Y.S., and Lee J.H. L1 cell adhesion molecule is a novel independent poor prognostic factor of extrahepatic cholangiocarcinoma Clin Cancer Res 15 2009 7345 7351
30. Li S.H., Li C.F., and Sung M.T. Skp2 is an independent prognosticator of gallbladder carcinoma among p27(Kip1)-interacting cell cycle regulators: an immunohistochemical study of 62 cases by tissue microarray Mod Pathol 20 2007 497 507
31. Kim W.B., Han H.J., and Lee H.J. Expression and clinical significance of cell cycle regulatory proteins in gallbladder and extrahepatic bile duct cancer Ann Surg Oncol 16 2009 23 34
32. Linnemann D., and Bock E. Expression of the cell adhesion molecules N-CAM and L1 in B16 melanoma cells Med Biol 64 1986 345 349 (Pubitemid 17226777)
33. Park J.S., Jung W.H., and Kim J.K. Estrogen receptor alpha, estrogen receptor beta, and progesterone receptor as possible prognostic factor in radically resected gallbladder carcinoma J Surg Res 152 2009 104 110
34. Kohya N., Kitajima Y., and Jiao W. Effects of E-cadherin transfection on gene expression of a gallbladder carcinoma cell line: repression of MTS1/S100A4 gene expression Int J Cancer 104 2003 44 53 (Pubitemid 36184145)
35. Choi Y.L., Xuan Y.H., and Shin Y.K. An immunohistochemical study of the expression of adhesion molecules in gallbladder lesions J Histochem Cytochem 52 2004 591 601 (Pubitemid 38658192)
36. Shtutman M., Levina E., and Ohouo P. Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells Cancer Res 66 2006 11370 11380 (Pubitemid 46009968)
37. Loers G., Chen S., and Grumet M. Signal transduction pathways implicated in neural recognition molecule L1 triggered neuroprotection and neuritogenesis J Neurochem 92 2005 1463 1476 (Pubitemid 40389215)
38. Villedieu M., Deslandes E., and Duval M. Acquisition of chemoresistance following discontinuous exposures to cisplatin is associated in ovarian carcinoma cells with progressive alteration of FAK, ERK and p38 activation in response to treatment Gynecol Oncol 101 2006 507 519 (Pubitemid 44251068)
39. Silletti S., Yebra M., and Perez B. Extracellular signal-regulated kinase (ERK)-dependent gene expression contributes to L1 cell adhesion molecule-dependent motility and invasion J Biol Chem 279 2004 28880 28888 (Pubitemid 38915755)
40. Schmalhofer O., Brabletz S., and Brabletz T. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer Cancer Metastasis Rev 28 2009 151 166
41. Whitaker H.C., Girling J., and Warren A.Y. Alterations in beta-catenin expression and localization in prostate cancer Prostate 68 2008 1196 1205
42. Wanitsuwan W., Kanngurn S., and Boonpipattanapong T. Overall expression of beta-catenin outperforms its nuclear accumulation in predicting outcomes of colorectal cancers World J Gastroenterol 14 2008 6052 6059
43. Pfeifer M., Schirmer U., and Geismann C. L1CAM expression in endometrial carcinomas is regulated by usage of two different promoter regions BMC Mol Biol 11 2010 64
44. Arlt M.J., Novak-Hofer I., and Gast D. Efficient inhibition of intra-peritoneal tumor growth and dissemination of human ovarian carcinoma cells in nude mice by anti-L1-cell adhesion molecule monoclonal antibody treatment Cancer Res 66 2006 936 943 (Pubitemid 43165961)
45. Knogler K., Grunberg J., and Zimmermann K. Copper-67 radioimmunotherapy and growth inhibition by anti-L1-cell adhesion molecule monoclonal antibodies in a therapy model of ovarian cancer metastasis Clin Cancer Res 13 2007 603 611 (Pubitemid 46225367)